# FDA 483 - Wendy C. Daly, M.D. - July 01, 2019

Source: https://www.keypedia.com/records/483/wendy-c-daly-md/1aa602af-ac2b-44fa-988a-93356d271a12

> FDA 483 for Wendy C. Daly, M.D. on July 01, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Wendy C. Daly, M.D.
- Inspection Date: 2019-07-01
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Wendy C. Daly, M.D. in Louisville, KY, a clinical investigator, revealed significant issues in clinical trial conduct. Observations included the failure to report adverse events to the sponsor and the lack of accurate and complete case histories, with discrepancies between source documents and electronic case report forms.

## Related Officers

- [investigator](https://www.keypedia.com/people/karen-m-cooper/4813e60d-c8da-4df2-bc48-ecfb06a55cf8)

Company: https://www.keypedia.com/companies/wendy-c-daly-md/e730d1a7-8622-4c23-ad76-a1c1c283b89b

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22